Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priority Income Fund J Pref | PRIF-J | Jan 14, 2025 | 23.14 | +0.43 |
Priority Income Fund Pref | PRIF-H | Jan 14, 2025 | 24.20 | -0.49 |
Priority Technology | PRTH | Jan 14, 2025 | 9.57 | +1.38 |
Privia Health Group | PRVA | Jan 14, 2025 | 21.00 | +1.25 |
Pro-Dex | PDEX | Jan 14, 2025 | 45.00 | -3.72 |
ProAssurance | PRA | Jan 14, 2025 | 15.00 | +3.23 |
Procaps Group | PROC | Jan 14, 2025 | 1.76 | +7.98 |
Procept BioRobotics | PRCT | Jan 14, 2025 | 82.00 | -1.10 |
Processa Pharmaceuticals | PCSA | Jan 14, 2025 | 0.83 | -0.46 |
Procore Technologies | PCOR | Jan 14, 2025 | 74.82 | +0.66 |
Procter & Gamble | PG | Jan 14, 2025 | 159.74 | +0.57 |
Professional Diversity Network | IPDN | Jan 14, 2025 | 0.45 | +2.27 |
Proficient Auto Logistics | PAL | Jan 14, 2025 | 9.70 | -4.62 |
Profire Energy | PFIE | Jan 14, 2025 | 2.54 | 0.00 |
Profound Medical | PROF | Jan 14, 2025 | 7.30 | -2.01 |
ProFrac A | ACDC | Jan 14, 2025 | 8.53 | +6.36 |
PROG | PRG | Jan 14, 2025 | 40.91 | -1.52 |
Progress Software | PRGS | Jan 14, 2025 | 62.49 | +0.64 |
Progressive | PGR | Jan 14, 2025 | 239.76 | +1.69 |
Progyny | PGNY | Jan 14, 2025 | 20.04 | -1.28 |
ProKidney | PROK | Jan 14, 2025 | 1.58 | -4.24 |
Prologis | PLD | Jan 14, 2025 | 108.12 | +2.61 |
ProMIS Neurosciences | PMN | Jan 14, 2025 | 0.94 | -5.82 |
PropertyGuru | PGRU | Jan 14, 2025 | 6.70 | 0.00 |
ProPetro | PUMP | Jan 14, 2025 | 10.49 | +2.04 |
ProPhase Labs | PRPH | Jan 14, 2025 | 0.61 | -6.70 |
ProQR Therapeutics | PRQR | Jan 14, 2025 | 2.26 | -0.44 |
PROS | PRO | Jan 14, 2025 | 21.95 | +1.67 |
ProShares Bitcoin Strategy ETF | BITO | Jan 14, 2025 | 23.44 | +3.08 |
Proshares Ultra FTSE Europe | UPV | Jan 14, 2025 | 54.27 | +1.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.